Geode Capital Management »

Moleculin Biotech shares owned by Geode Capital Management

Quarter-by-quarter ownership of Moleculin Biotech shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Moleculin Biotech

Tip: Access up to 7 years of quarterly data

All positions including Moleculin Biotech held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moleculin Biotech by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $98k 17k 5.91

More positions owned by Geode Capital Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Visa Inc-class A Shares Com Cl A (V)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)

View all positions for Geode Capital Management

Top funds holding Moleculin Biotech

Armistice Capital
Vanguard Group
Geode Capital Management
BlackRock
Atticus Wealth Management
Newbridge Financial Services Group
Tower Research Capital
Morgan Stanley
Fwl Investment Management
Sandy Spring Bank
Advisor Group Holdings
Wells Fargo & Company
North Star Investment Management
Nbc Securities
Royal Bank of Canada

View all funds holding Moleculin Biotech